IS5730A - Setin tíazóló-pýridazín afleiða, lyfjasamsetningar gerðar úr henni - Google Patents

Setin tíazóló-pýridazín afleiða, lyfjasamsetningar gerðar úr henni

Info

Publication number
IS5730A
IS5730A IS5730A IS5730A IS5730A IS 5730 A IS5730 A IS 5730A IS 5730 A IS5730 A IS 5730A IS 5730 A IS5730 A IS 5730A IS 5730 A IS5730 A IS 5730A
Authority
IS
Iceland
Prior art keywords
pharmaceutical formulations
pyridazine derivatives
substituted thiazolo
thiazolo
substituted
Prior art date
Application number
IS5730A
Other languages
English (en)
Other versions
IS2258B (is
Inventor
Robert Carling William
Luis Castro Pineiro Jose
Madin Andrew
Joseph Street Leslie
John Cowden Cameron
John Davies Antony
Francis Mccabe James
Edward Stephen Pearce Gareth
Original Assignee
Merck Sharp & Dohme Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp & Dohme Limited filed Critical Merck Sharp & Dohme Limited
Publication of IS5730A publication Critical patent/IS5730A/is
Publication of IS2258B publication Critical patent/IS2258B/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IS5730A 1998-06-24 2000-11-24 Setin tríasóló-pýridasín afleiða, lyfjasamsetningar gerðar úr henni IS2258B (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9813576.7A GB9813576D0 (en) 1998-06-24 1998-06-24 Therapeutic agents
PCT/GB1999/001897 WO1999067245A1 (en) 1998-06-24 1999-06-15 A substituted triazolo-pyridazine derivative, pharmaceutical compositions made therefrom

Publications (2)

Publication Number Publication Date
IS5730A true IS5730A (is) 2000-11-24
IS2258B IS2258B (is) 2007-06-15

Family

ID=10834265

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5730A IS2258B (is) 1998-06-24 2000-11-24 Setin tríasóló-pýridasín afleiða, lyfjasamsetningar gerðar úr henni

Country Status (35)

Country Link
US (1) US6630471B1 (is)
EP (1) EP1090004B1 (is)
JP (1) JP4749545B2 (is)
KR (1) KR100604108B1 (is)
CN (1) CN1138779C (is)
AR (1) AR018925A1 (is)
AT (1) ATE239730T1 (is)
AU (1) AU757315B2 (is)
BG (1) BG64989B1 (is)
BR (1) BR9911563A (is)
CA (1) CA2335328C (is)
CO (1) CO5031239A1 (is)
CZ (1) CZ291409B6 (is)
DE (1) DE69907675T2 (is)
EA (1) EA003332B1 (is)
EE (1) EE200000767A (is)
ES (1) ES2196824T3 (is)
GB (1) GB9813576D0 (is)
GE (1) GEP20033143B (is)
HR (1) HRP20000879A2 (is)
HU (1) HUP0102894A3 (is)
ID (1) ID27771A (is)
IL (2) IL139775A0 (is)
IS (1) IS2258B (is)
MY (1) MY124341A (is)
NO (1) NO317992B1 (is)
NZ (1) NZ508290A (is)
PE (1) PE20000710A1 (is)
PL (1) PL204650B1 (is)
RS (1) RS49746B (is)
SK (1) SK285307B6 (is)
TR (1) TR200003789T2 (is)
TW (1) TWI222449B (is)
WO (1) WO1999067245A1 (is)
ZA (1) ZA200007485B (is)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2345443A (en) * 1999-01-08 2000-07-12 Merck Sharp & Dohme Use of triazolo-pyridazines for treating premenstrual syndrome
US20050042194A1 (en) 2000-05-11 2005-02-24 A.P. Pharma, Inc. Semi-solid delivery vehicle and pharmaceutical compositions
GB0111191D0 (en) * 2001-05-08 2001-06-27 Merck Sharp & Dohme Therapeutic agents
WO2004058769A2 (en) 2002-12-18 2004-07-15 Vertex Pharmaceuticals Incorporated Triazolopyridazines as protein kinases inhibitors
WO2006061428A2 (en) * 2004-12-10 2006-06-15 Universität Zürich Gaba-a alpha 2 and alpha 3 receptor agonists for treating neuropathic, inflammatory and migraine associated pain
JP2012531419A (ja) 2009-06-23 2012-12-10 コンサート ファーマシューティカルズ インコーポレイテッド Ｇａｂａ−ａ受容体修飾物質としての重水素修飾されたトリアゾロピリダジン誘導体
WO2011011712A1 (en) * 2009-07-24 2011-01-27 Concert Pharmaceuticals, Inc. Substituted imidazotriazines
WO2011047315A1 (en) 2009-10-15 2011-04-21 Concert Pharmaceuticals, Inc. Subsitituted benzimidazoles
PH12012501361A1 (en) 2009-12-31 2012-10-22 Centro Nac De Investigaciones Oncologicas Cnio Tricyclic compounds for use as kinase inhibitors
WO2012098387A1 (en) * 2011-01-18 2012-07-26 Centro Nacional De Investigaciones Oncológicas (Cnio) 6, 7-ring-fused triazolo [4, 3 - b] pyridazine derivatives as pim inhibitors
WO2013045519A1 (en) 2011-09-27 2013-04-04 Genfit Derivatives of 6-substituted triazolopyridazines as rev-erb agonists
WO2017129801A1 (en) 2016-01-27 2017-08-03 Universität Zürich Use of gabaa receptor modulators for treatment of itch
BR112020021104A2 (pt) * 2018-04-18 2021-02-23 Neurocycle Therapeutics, Inc compostos moduladores alostéricos positivos gabaa, métodos de produção e usos dos mesmos
BR112021004661A2 (pt) * 2018-09-13 2021-06-01 Saniona A/S composto, composição farmacêutica, método para tratamento de dor neuropática e/ou prurido, e, uso do composto
HU231223B1 (hu) 2018-09-28 2022-01-28 Richter Gedeon Nyrt. GABAA A5 receptor modulátor hatású biciklusos vegyületek
EP4126858B1 (en) 2020-03-26 2026-03-18 Richter Gedeon Nyrt. Dihydro-2-pyrrolo[3,4-c]pyridine derivatives as gabaa a5 receptor modulators
WO2025141131A1 (en) 2023-12-27 2025-07-03 Saniona A/S A gabaa receptor ligand and the use thereof in medicine, in particular in the treatment of epilepsy
WO2026082004A1 (zh) * 2024-10-14 2026-04-23 上海京新生物医药有限公司 稠合杂芳基衍生物及其制备方法与应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20000029548A (ko) * 1996-07-25 2000-05-25 더블유. 지. 콜 가바수용체에대한리간드로서의치환된트리아졸로-피리다진유도체

Also Published As

Publication number Publication date
DE69907675T2 (de) 2004-03-04
SK285307B6 (sk) 2006-10-05
IL139775A (en) 2007-02-11
WO1999067245A1 (en) 1999-12-29
US6630471B1 (en) 2003-10-07
CO5031239A1 (es) 2001-04-27
ID27771A (id) 2001-04-26
ATE239730T1 (de) 2003-05-15
NO20006576L (no) 2001-02-14
EE200000767A (et) 2002-06-17
EA200100071A1 (ru) 2001-06-25
CZ291409B6 (cs) 2003-03-12
BR9911563A (pt) 2001-03-20
CA2335328A1 (en) 1999-12-29
EP1090004B1 (en) 2003-05-07
TWI222449B (en) 2004-10-21
BG105152A (en) 2001-10-31
HUP0102894A2 (hu) 2001-11-28
RS49746B (sr) 2008-04-04
AU4630199A (en) 2000-01-10
NO20006576D0 (no) 2000-12-21
DE69907675D1 (de) 2003-06-12
AR018925A1 (es) 2001-12-12
KR100604108B1 (ko) 2006-07-26
CN1307579A (zh) 2001-08-08
PL204650B1 (pl) 2010-01-29
JP2002518501A (ja) 2002-06-25
BG64989B1 (bg) 2006-11-30
MY124341A (en) 2006-06-30
SK19552000A3 (sk) 2001-08-06
KR20010053136A (ko) 2001-06-25
IL139775A0 (en) 2002-02-10
GEP20033143B (en) 2003-12-25
NZ508290A (en) 2003-09-26
HRP20000879A2 (en) 2001-06-30
NO317992B1 (no) 2005-01-17
ES2196824T3 (es) 2003-12-16
ZA200007485B (en) 2002-01-07
JP4749545B2 (ja) 2011-08-17
PL345332A1 (en) 2001-12-17
CA2335328C (en) 2007-11-27
AU757315B2 (en) 2003-02-13
EP1090004A1 (en) 2001-04-11
GB9813576D0 (en) 1998-08-19
HUP0102894A3 (en) 2003-03-28
CN1138779C (zh) 2004-02-18
TR200003789T2 (tr) 2001-04-20
EA003332B1 (ru) 2003-04-24
YU77800A (sh) 2003-10-31
IS2258B (is) 2007-06-15
CZ20004872A3 (cs) 2001-07-11
PE20000710A1 (es) 2000-08-14

Similar Documents

Publication Publication Date Title
TR199901077A3 (tr) Ispençiyari formülasyonlar.
FI991485A0 (fi) Uusi farmaseuttinen koostumus
NO20012915L (no) Ny farmasöytisk formulering
NO20015175L (no) Farmasöytisk sammensetning
DE60019577D1 (de) 4, 5, 6, 7-tetrahydroindazolderivate als antitumormittel
PT1140935E (pt) Derivados da quinolina 1,2-ciclizada
PT1242087E (pt) Composicoes farmaceuticas
ID27415A (id) Komposisi farmaseutik
PT1244641E (pt) Derivados da tiazolilamida
NO20005832L (no) Nye spesielle formuleringer
FIU20000164U0 (fi) Uusi farmaseuttinen formulaatio
IS5730A (is) Setin tíazóló-pýridazín afleiða, lyfjasamsetningar gerðar úr henni
ID29262A (id) Komposisi farmasi
PT1187814E (pt) Derivados da 5-fenil-pirimidina
DK1466615T3 (da) Farmaceutisk præparat
NO20015670L (no) Forbedrede farmasöytiske formuleringer
ID27201A (id) Komposisi farmasi
ATE309220T1 (de) Substituierte 1,2,3,4-tetrahydrochinolin-2- carbonsäurederivate
PT1239832E (pt) Composicoes farmaceuticas
DE60025958D1 (de) 14,15-beta-methylen substituierte androgene
ID30032A (id) Formulasi farmasi
NO20021866L (no) Ciclesonid-inneholdende vandig farmasoytisk blanding
FI4488U1 (fi) Farmaseuttinen koostumus
AR025867A1 (es) Formulacion portasdora farmaceutica
EE04217B1 (et) Farmatseutilised kompositsioonid